Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vertex Pharmaceuticals
(NQ:
VRTX
)
417.79
-1.03 (-0.25%)
Streaming Delayed Price
Updated: 11:14 AM EDT, May 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vertex Pharmaceuticals
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
42
43
Next >
2 Top Healthcare Stocks Defying the Bear Market
October 26, 2023
These companies are building out their revenue and profit streams, and the proof is in the pudding.
Via
The Motley Fool
This Market-Beating Growth Stock Is Set to Outperform Yet Again in 2024
October 26, 2023
This rare disease company is on a roll.
Via
The Motley Fool
2 Best Healthcare Stocks to Buy Right Now
October 26, 2023
The healthcare industry is an explosive space full of promising, profitable companies.
Via
The Motley Fool
Vertex Pharmaceuticals: Buy at the High?
October 26, 2023
Vertex shares have been flying high in recent times.
Via
The Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
October 26, 2023
Great healthcare businesses are out there and their stocks are ripe for the picking.
Via
The Motley Fool
2 No-Brainer Growth Stocks to Buy Right Now
October 26, 2023
These businesses are thriving and raking in profits.
Via
The Motley Fool
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings
October 20, 2023
Via
Benzinga
The Latest Analyst Ratings for Vertex Pharmaceuticals
October 16, 2023
Via
Benzinga
Is Vertex Pharmaceuticals Stock a Buy Now?
October 15, 2023
Jim Cramer recently hyped up one of the company's promising drugs.
Via
The Motley Fool
2 Fantastic Growth Stocks to Buy Hand Over Fist
October 26, 2023
These stocks make great bargains today.
Via
The Motley Fool
3 Red-Hot Growth Stocks That Are Still Cheap Buys
October 25, 2023
It's not too late to invest in these great businesses.
Via
The Motley Fool
Apellis Pharmaceuticals Stock Shows Rising Relative Strength
October 24, 2023
A Relative Strength Rating upgrade for Apellis Pharmaceuticals shows improving technical performance. Will it continue?
Via
Investor's Business Daily
The Best Stocks to Invest $5,000 In Right Now
October 24, 2023
Today, the following three healthcare players look like fantastic bargains.
Via
The Motley Fool
3 Unstoppable Stocks to Buy Sooner Rather Than Later
October 22, 2023
Now is the time to invest in these great stocks.
Via
The Motley Fool
3 Monster Stocks to Buy Without Any Hesitation
October 20, 2023
These big stocks could become a lot bigger.
Via
The Motley Fool
If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today
October 13, 2023
Via
Benzinga
2 Top Biotech Stocks to Buy Right Now
October 12, 2023
Both companies are known innovators.
Via
The Motley Fool
4 Ways to Grow $100,000 Into $1 Million for Retirement
October 19, 2023
Investing for big-time growth doesn't have to be risky.
Via
The Motley Fool
Vertex Pharmaceuticals, Gilead Sciences And 2 Other Stocks Insiders Are Selling
October 19, 2023
The Nasdaq 100 closed lower by over 200 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
3 Gene Editing Stocks to Generate Super-Charged Gains
October 18, 2023
As things progress, such techniques may be able to knock out every disease known, creating massive opportunity for gene-editing stocks.
Via
InvestorPlace
Intellia Stumbles As It Aims For A First-Ever In CRISPR Gene Editing
October 18, 2023
The company can begin a pivotal study of its treatment for cardiomyopathy.
Via
Investor's Business Daily
The Stock Market Is Resilient But How Long Will It Last? Your Mid-October Update
October 17, 2023
We're continuing to see resilience in the US Stock Market in the headwinds of otherwise bearish or bad news, but is this the beginning of a larger rally or may the resiliency come to an end soon?
Via
Talk Markets
Mixed Signals For CRISPR Therapeutics, Analyst Weighs Barriers, Potential Sales For Sickle Cell Therapy
October 17, 2023
Cantor Fitzgerald has downgraded CRISPR Therapeutics AG (NASDAQ: CRSP) to Neutral from Ov
Via
Benzinga
Healthcare Portfolio Focus Stocks
October 16, 2023
The macro news has been a steady headwind with rising rates offering 5% risk-free treasury yields.
Via
Talk Markets
Revolution Medicines Stock Joins Elite Club With RS Ratings Over 90
October 16, 2023
Revolution Medicines shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
2 Healthcare Stocks Near 52-Week Highs Still Worth Buying
October 16, 2023
These two large-cap biopharma companies could have more room to run.
Via
The Motley Fool
This Cathie Wood Stock Is Set to Soar 100%, Says Wall Street
October 16, 2023
This Wood favorite is heading for a big moment.
Via
The Motley Fool
2 Growth Stocks That Could Double Your Money, According to Wall Street
October 15, 2023
Find out why investment bank analysts are pounding the table on these stocks.
Via
The Motley Fool
3 Top Healthcare Stocks to Buy for October
October 12, 2023
These stocks have oodles of room left to run.
Via
The Motley Fool
Cathie Wood Is Buying CRISPR Therapeutics Ahead of This Big Event. Should You?
October 10, 2023
Wood has outperformed the market so far this year.
Via
The Motley Fool
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
42
43
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.